nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adding rituximab to cyclophosphamide, vincristine and prednisone increases time to treatment failure or progression in people with untreated stage III/IV follicular lymphoma
|
Ghielmini, Michele |
|
2005 |
31 |
8 |
p. 644-647 4 p. |
artikel |
2 |
Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer
|
Lamberti, C. |
|
2005 |
31 |
8 |
p. 648-652 5 p. |
artikel |
3 |
Bortezomib, a novel proteasome inhibitor, in the treatment of hematologic malignancies
|
Jackson, Graham |
|
2005 |
31 |
8 |
p. 591-602 12 p. |
artikel |
4 |
Editorial board
|
|
|
2005 |
31 |
8 |
p. CO2- 1 p. |
artikel |
5 |
High-quality evidence in oncology from 19 May to 9 June 2005: A summary
|
Djulbegovic, Benjamin |
|
2005 |
31 |
8 |
p. 653-656 4 p. |
artikel |
6 |
Radical prostatectomy for early prostate cancer improves long term survival
|
Alibhai, Shabbir M.H. |
|
2005 |
31 |
8 |
p. 640-643 4 p. |
artikel |
7 |
Taxanes in the treatment of early breast cancer
|
Ring, Alistair E. |
|
2005 |
31 |
8 |
p. 618-627 10 p. |
artikel |
8 |
The challenge of systematic reviews of diagnostic and staging studies in cancer
|
Lyman, Gary H. |
|
2005 |
31 |
8 |
p. 628-639 12 p. |
artikel |
9 |
The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer
|
Madhusudan, Srinivasan |
|
2005 |
31 |
8 |
p. 603-617 15 p. |
artikel |